COMPARE GENERIKS INC
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: COMPARE GENERIKS INC, 10-Q, 2000-08-11
Next: GENSYM CORP, 10-Q, 2000-08-11



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The schedule contains summary financial information extracted from the financial
statements and is qualified in its entirety by reference to such financial
statements
</LEGEND>

<MULTIPLIER>                                   1


<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-END>                                   JUN-30-2000
<CASH>                                             134,217
<SECURITIES>                                             0
<RECEIVABLES>                                    2,962,334
<ALLOWANCES>                                        10,000
<INVENTORY>                                      7,654,550
<CURRENT-ASSETS>                                11,000,216
<PP&E>                                              79,482
<DEPRECIATION>                                      39,696
<TOTAL-ASSETS>                                  11,679,890
<CURRENT-LIABILITIES>                            7,112,692
<BONDS>                                                  0
                                    0
                                            590
<COMMON>                                               491
<OTHER-SE>                                       4,566,117
<TOTAL-LIABILITY-AND-EQUITY>                    11,679,890
<SALES>                                         10,957,982
<TOTAL-REVENUES>                                10,957,982
<CGS>                                            9,923,832
<TOTAL-COSTS>                                    9,923,832
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                    158,278
<INCOME-TAX>                                        41,000
<INCOME-CONTINUING>                                117,278
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       117,278
<EPS-BASIC>                                            .02
<EPS-DILUTED>                                          .02



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission